Rachel McMinn
2015
In 2015, Rachel McMinn earned a total compensation of $2.1M as Chief Strategy and Business Officer at Intercept Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
| Bonus | $156,000 |
|---|---|
| Option Awards | $933,713 |
| Salary | $390,000 |
| Stock Awards | $619,196 |
| Other | $16,508 |
| Total | $2,115,417 |
McMinn received $933.7K in option awards, accounting for 44% of the total pay in 2015.
McMinn also received $156K in bonus, $390K in salary, $619.2K in stock awards and $16.5K in other compensation.
Rankings
In 2015, Rachel McMinn's compensation ranked 4,506th out of 13,638 executives tracked by ExecPay. In other words, McMinn earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,506 out of 13,638 | 67th |
Division Manufacturing | 1,641 out of 5,187 | 68th |
Major group Chemicals And Allied Products | 595 out of 1,857 | 68th |
Industry group Drugs | 472 out of 1,531 | 69th |
Industry Pharmaceutical Preparations | 372 out of 1,179 | 68th |
Source: SEC filing on June 20, 2016.
McMinn's colleagues
We found five more compensation records of executives who worked with Rachel McMinn at Intercept Pharmaceuticals in 2015.
2015
Mark Pruzanski
Intercept Pharmaceuticals
Chief Executive Officer
2015
Lisa Bright
Intercept Pharmaceuticals
Chief Commercial and Corporate Affairs Officer
2015
David Shapiro
Intercept Pharmaceuticals
Chief Medical Officer
2015
Barbara Duncan
Intercept Pharmaceuticals
Chief Financial Officer
2015
Daniel Regan
Intercept Pharmaceuticals